GoodRx Holdings, Inc. GDRX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 92.8%-1.1pp | 93.9%+2.8pp | 91.1%-0.4pp | 91.5%-2.2pp | |
| Operating margin | 11%+2.7pp | 8.3%+11.9pp | -3.6%-3.8pp | 0.2%-1.6pp | |
| Net margin | 3.8%+1.8pp | 2.1%+3.3pp | -1.2%+3.1pp | -4.3%-0.9pp | |
| Returns | |||||
| Return on equity | 4.5%+2.3pp | 2.2%+3.3pp | -1.1%+2.9pp | -4%-0.7pp | |
| Return on invested capital | 5.5%+1.3pp | 4.2%+7.7pp | -3.4%-3.7pp | 0.3%-2.3pp | |
| Efficiency | |||||
| Asset turnover | 0.6×0.0× | 0.5×+0.1× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | |||||
| Current ratio | 2.6×-2.7× | 5.3×-1.8× | 7.1×-4.9× | 12.1×-1.4× | |
| Leverage | |||||
| Debt-to-equity | 0.9×+0.1× | 0.7×-0.2× | 0.9×+0.1× | 0.9×0.0× | |
| Net debt / EBITDA | 1.6×+0.9× | 0.7×+0.2× | 0.5×+1.2× | -0.7×+4.3× | |
| Per Share | |||||
| Book value per share | $1.73-6.6% | $1.85-0.5% | $1.86-5.9% | $1.97-2.7% | |
| Valuation | |||||
| Market capitalization | $934.74M-43.1% | $1.77B-34.4% | $2.7B+40.8% | $1.92B-85.8% | |
| Price / earnings | 45.5×-12.3× | 108.1×— | —— | —— | |
| Price / sales | 1.2×-0.9× | 2.2×-1.4× | 3.6×+1.1× | 2.5×-15.7× | |
| Price / book | 1.5×-1.0× | 2.4×-1.1× | 3.5×+1.2× | 2.4×-13.9× | |
| EV / EBITDA | 7.6×-4.5× | 13.8×-20.2× | 34×+0.4× | 33.6×-244× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GoodRx Holdings, Inc.'s profit margins?
- GoodRx Holdings, Inc. (GDRX) runs a 91.8% gross margin and a 9.9% operating margin, with a 2.6% net margin.
- Where do GoodRx Holdings, Inc.'s ratios come from?
- Every ratio is computed from GoodRx Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
